Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « Auteurs » - entrée « Nobuhiro Takagi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nobuhiro Kamiya < Nobuhiro Takagi < Nobuhisa Yamada  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000A31 (2018) Tatsuya Atsumi [Japon] ; Yoshiaki Ando [Japon] ; Shinichi Matsuda [Japon] ; Shiho Tomizawa [Japon] ; Riwa Tanaka [Japon] ; Nobuhiro Takagi [Japon] ; Ayako Nakasone [Japon]Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database.
000D99 (2017) Naoki Ishiguro [Japon] ; Tatsuya Atsumi [Japon] ; Masayoshi Harigai [Japon] ; Tsuneyo Mimori [Japon] ; Norihiro Nishimoto [Japon] ; Takayuki Sumida [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Ayako Nakasone [Japon] ; Nobuhiro Takagi ; Hisashi Yamanaka [Japon]Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
001540 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
001541 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiDrug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
001B66 (2010) Norihiro Nishimoto [Japon] ; Nobuhiro TakagiAssessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study.
001C00 (2010) Norihiro Nishimoto [Japon] ; Kyoko Ito ; Nobuhiro TakagiSafety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions.
001D21 (2008) Norihiro Nishimoto [Japon] ; Kimio Terao ; Toru Mima ; Hideko Nakahara ; Nobuhiro Takagi ; Takahiro KakehiMechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Nobuhiro Takagi" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Nobuhiro Takagi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Nobuhiro Takagi
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021